Chris McArdle

Chris McArdle, Partner, Alston & Bird LLP

Christopher L. McArdle is an intellectual property litigation partner in Alston & Bird's New York office. His practice focuses on high-stakes patent litigation, with extensive trial experience in federal courts across the country. McArdle's technical specializations include medical devices, pharmaceuticals (including Hatch-Waxman litigation), and software. His work also encompasses Lanham Act litigation, appellate advocacy before the Federal Circuit, and counseling clients on patent monetization strategies.

While the provided case list shows one recent appearance on the plaintiff side for Unified Patents in a dispute with Centripetal Networks, McArdle’s broader practice involves representing both plaintiffs and defendants. His representative matters include defending a medical device manufacturer in a patent license dispute, representing a pharmaceutical company in litigation related to the drug dronedarone, and representing an electronics manufacturer in a case involving Wi-Fi and video standards.

McArdle has significant experience in post-grant proceedings before the Patent Trial and Appeal Board (PTAB), where he has secured victories for clients in inter partes review (IPR) proceedings. His public biography lists his involvement in IPRs concerning pharmaceuticals and electrical technology. He holds a degree in chemistry.